Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis
- PMID: 26488500
- PMCID: PMC4621165
- DOI: 10.12659/msm.895257
Common Polymorphisms in the NFKBIA Gene and Cancer Susceptibility: A Meta-Analysis
Abstract
Background: NFKBIA encodes the inhibitors of nuclear factor-κB (NF-κB), which regulate the translation of the genes involved in the inflammatory and immune reactions. Polymorphisms (rs2233406, rs3138053, and rs696) of NFKBIA have been implicated in susceptibility to many cancer types.
Material and methods: To evaluate the association between polymorphisms of NFKBIA and cancer susceptibility, a meta-analysis including a total of 7182 cancer cases and 10 057 controls from 28 case-control studies was performed. Data were extracted and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.
Results: Combined data demonstrated that rs3138053 polymorphism of NFKBIA was associated with cancer susceptibility in an allelic model (C vs. T: OR=10.754, 95%CI=4.175-27.697, Pheterogeneity=0.000), while the polymorphism of rs696 appeared to play a protective role in tumorigenesis (CC+CT vs. TT: OR=0.879, 95%CI=0.787-0.982, Pheterogeneity=0.107). When stratification analysis was performed by cancer type, an increased association of rs3138053 was recognized in hepatocarcinoma (C vs. T: OR=42.180, 95%CI=27.970-63.612, Pheterogeneity=0.007), while a decreased association of rs696 was identified in Hodgkin lymphoma (C vs. T: OR=0.792, 95%CI=0.656-0.956, Pheterogeneity=0.116; CC vs. TT: OR=0.658, 95%CI=0.448-0.965, Pheterogeneity=0.076; CC vs. CT+TT: OR=0.734, 95%CI=0.562-0.958, Pheterogeneity=0.347). By ethnicity, rs696 appears to be a protective candidate among Caucasians (CT vs. TT: OR=0.809, 95%CI=0.676-0.969, Pheterogeneity=0.459).
Conclusions: Our data demonstrated that the rs3138053 polymorphism of NFKBIA gene is a candidate for susceptibility to overall cancers, while rs696 plays a protective role.
Figures






Similar articles
-
Association of the NFKBIA gene polymorphisms with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.Inflamm Res. 2011 Jan;60(1):11-8. doi: 10.1007/s00011-010-0216-2. Epub 2010 May 21. Inflamm Res. 2011. PMID: 20495844
-
Association between inflammatory-response gene polymorphisms and risk of acute kidney injury in children.Biosci Rep. 2018 Dec 14;38(6):BSR20180537. doi: 10.1042/BSR20180537. Print 2018 Dec 21. Biosci Rep. 2018. PMID: 30429237 Free PMC article.
-
Polymorphism in NFKBIA gene is associated with recurrent acute rejections in liver transplant recipients.Tissue Antigens. 2014 Oct;84(4):370-7. doi: 10.1111/tan.12411. Epub 2014 Aug 11. Tissue Antigens. 2014. PMID: 25112903
-
Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.J BUON. 2015 May-Jun;20(3):902-17. J BUON. 2015. PMID: 26214646 Review.
-
STK15 rs2273535 polymorphism and cancer risk: a meta-analysis of 74,896 subjects.Cancer Epidemiol. 2014 Apr;38(2):111-7. doi: 10.1016/j.canep.2013.10.008. Epub 2013 Nov 16. Cancer Epidemiol. 2014. PMID: 24252226 Review.
Cited by
-
Network Pharmacology-Based Strategy for Elucidating the Molecular Basis Forthe Pharmacologic Effects of Licorice (Glycyrrhiza spp.).Front Pharmacol. 2021 Apr 28;12:590477. doi: 10.3389/fphar.2021.590477. eCollection 2021. Front Pharmacol. 2021. PMID: 33995004 Free PMC article.
-
Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients.Hum Immunol. 2022 Aug-Sep;83(8-9):613-617. doi: 10.1016/j.humimm.2022.06.002. Epub 2022 Jun 21. Hum Immunol. 2022. PMID: 35777990 Free PMC article.
-
NFKBIE is a predictive factor of survival and is correlated with immune infiltration and antigen processing and presentation in hepatocellular carcinoma.Oncol Lett. 2024 Aug 6;28(4):480. doi: 10.3892/ol.2024.14613. eCollection 2024 Oct. Oncol Lett. 2024. PMID: 39161335 Free PMC article.
-
The association between NFKB1 -94ATTG ins/del and NFKB1A 826C/T genetic variations and coronary artery disease risk.Mol Biol Res Commun. 2018 Mar;7(1):17-24. doi: 10.22099/mbrc.2018.28261.1302. Mol Biol Res Commun. 2018. PMID: 29911119 Free PMC article.
-
The genetic polymorphisms of immune-related genes contribute to the susceptibility and survival of lymphoma.Cancer Med. 2023 Jul;12(14):14960-14978. doi: 10.1002/cam4.6131. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37329186 Free PMC article.
References
-
- Domingo-Domenech J, Oliva C, Rovira A, et al. Interleukin 6, a nuclear factor-kappaB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-kappaB inhibition by PS-1145 enhances docetaxel antitumor activity. Clin Cancer Res. 2006;12(18):5578–86. - PubMed
-
- Ahn KS, Sethi G, Aggarwal BB. Nuclear factor-kappa B: from clone to clinic. Curr Mol Med. 2007;7(7):619–37. - PubMed
-
- Lind DS, HS, Malaty J, Rekkas S, et al. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery. 2001;130:363–69. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources